Healthcare -
Biotechnology - NASDAQ - GB
$ 11.311
-0.519 %
$ 8.23 B
Market Cap
2.04
P/E
ROIV - REVENUE
Revenue ROIV - Roivant Sciences Ltd.
125 M
LAST VALUE
50.24%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR